Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Biden says Americans will be first to get vaccines; any surplus to be shared

Published 03/10/2021, 04:16 PM
Updated 03/10/2021, 07:05 PM
© Reuters. U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington
JNJ
-

WASHINGTON (Reuters) - The U.S. government will first give Americans COVID-19 vaccines, but any surplus would be shared with the world, President Joe Biden said on Wednesday after earlier announcing plans to procure an additional 100 million doses.

"We're going to start off and ensure Americans are taken care of first, but we're then going to try to help the rest of the world," Biden told reporters following an earlier announcement to secure more vaccines with the chief executives of Johnson & Johnson (NYSE:JNJ) and Merck.

"If we have a surplus, we're going to share it with the rest of the world," Biden said, adding that the United States had already committed to providing $4 billion to the COVAX global initiative to distribute vaccines in developing countries.

The Democratic president said it was clear that the pandemic would not be over until it was ended everywhere.

"We're not going to be ultimately safe, until the world is safe," he said.

White House Press Secretary Jen Psaki told reporters that Biden was deeply focused on expanding global vaccinations, but the U.S. government was pushing to first ensure sufficient doses for people in the United States who wanted to get vaccinated.

She said Biden was discussing the need to ensure vaccines got to developing countries with his counterparts, but gave no details.

The United States, Britain, European Union nations and other richer members of the World Trade Organization (WTO) on Wednesday blocked a push by more than 80 developing countries to waive patent rights in an effort to boost production of COVID-19 vaccines for poor nations.

South Africa and India are leading the push for a temporary waiver of the rules of the WTO's Trade-Related Aspects of Intellectual Property (TRIPS) agreement, a move that could allow generic or other manufacturers to make more vaccines.

© Reuters. U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington

Western nations argue that protecting intellectual property rights encourages research and innovation, and suspending those rights would not result in a sudden surge of vaccine supply.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.